Reduced azithromycin susceptibility in Shigella sonnei, United States

Microbial Drug Resistance

Volumn 16, Issue 4, 2010, Pages 245-248

  Howie, Rebecca Leigh ^a,b   Folster, Jason P ^a,b   Bowen, Anna ^a   Barzilay, Ezra J ^a   Whichard, Jean M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Ihrc Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFOXITIN; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHIGELLA SONNEI; UNITED STATES;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; HUMANS; MICROBIAL SENSITIVITY TESTS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PLASMIDS; POLYMERASE CHAIN REACTION; SHIGELLA SONNEI; UNITED STATES;

ESCHERICHIA COLI; SHIGELLA SONNEI;

EID: 78650161451     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2010.0028     Document Type: Article

References (14)

1. American Academy of Pediatrics. 2003. Shigella infections. In L.K. Pickering (ed.), Red Book: 2003 Report of the Committee on Infectious Diseases, 26th edition. American Academy of Pediatrics, Elk Frove Village, IL, pp. 552-553.
2. Boumghar-Bourtchai, L., P. Mariani-Kurkdjian, E. Bingen, I. Filliol, A. Dhalluin, S.A. Ifrane, et al. 2008. Macrolideresistant Shigella sonnei. Emerg Infect Dis [serial on the Internet] [cited Jan. 13, 2010]. Available at www.cdc.gov/EID/content/14/8/1297.htm. (Online, last accessed May 7, 2010.)
3. Carattoli, A., A. Bertini, L. Villa, V. Falbo, K.L. Hopkins, and E.J. Threlfall. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228.
4. [CDC] Centers for Disease Control and Prevention. 2009. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2006 [cited Jan. 13, 2010]. Available at www.cdc.gov/narms/annual/2006/NARMSAnnualReport2006.pdf ., Atlanta, Georgia: U.S. Department of Health and Human Services, CDC. (Online, last accessed May 7, 2010 1 2010
5. [CLSI] Clinical Laboratory Standards Institute. 2007. Performance Standards for Antimicrobial Susceptibility Testing. M100-S17. Clinical Laboratory Standards Institute, Wayne, PA.
6. DuPont, H.L. 2009. Bacterial diarrhea. N. Engl. J. Med. 361:1560-1569.
7. Folster, J.P., G. Pecic, S. Bolcen, L. Theobald, K. Hise, A. Carattoli, S. Zhao, P.F. McDermott, and J.M. Whichard. 2010. Characterization of Extended-Spectrum Cephalosporin- Resistant Salmonella enterica Serovar Heidelberg Isolated from Humans in the United States. Foodborne Pathog. Dis. 7 [Epub ahead of print] 2009. [cited Jan. 13, 2010]. Available at www.liebertonline.com/doi/pdf/10.1089/fpd.2009.0376 . (Online.)
8. Jain, S.K., A. Gupta, B. Glanz, J. Dick, and G.K. Siberry. 2005. Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility. Pediatr. Infect. Dis. J. 24:494-497.
9. Kotloff, K., J.P. Winickoff, B. Ivanoff, J.D. Clemens, D.L. Swerdlow, P.J. Sansonetti, et al. 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. W.H.O 77: 651-666.
10. Mead, P.S., L. Slutsker, V. Dietz, L.F. McCaig, J.S. Bresee, C. Shapiro, et al. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625.
11. Noguchi, N., A. Emura, H. Matsuyama, K. OHara, M. Sasatsu, and M. Kono. 1995. Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 20-phosphotransferase I in Escherichia coli. Antimicrob. Agents Chemother. 39:2359-2363.
12. Philippon, A., R. Cluzel, and C.J. Soussy. 1995. [Azithromycin: breakpoints]. Azithromycine: points critiques. Pathol. Biol. 43:488-497. (In French.)
13. Rahman, M., S. Shoma, H. Rashid, S.E. Arifeen, A.H. Baqui, A.K. Siddique, et al. 2007. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J. Health Popul. Nutr. 25: 158-167.
14. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.